Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

A woman with severe angioedema improved significantly after treatment with rituximab.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Obese children respond worse to CARP treatment than non-obese children.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

We need safe, affordable drugs to fight coronaviruses effectively.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Deucravacitinib helped a man regrow hair significantly.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Finasteride may help improve certain brain function issues linked to dopamine.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

ATP-sensitive potassium channels play a role in chloroquine-induced itch in mice.

Activated protein C helps protect mice from radiation damage.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.